Page 22 - ITPS-5-2
P. 22

16    INNOSC Theranostics and Pharmacological Sciences, 2022, Vol. 5, No. 2          Govender and Hodkinson

            Table 1. 1999 international consensus statement     Laboratory Services (NHLS) at a state-sector
            guidelines of indications for ANCA testing* [1]     tertiary  hospital  over 12  months. Case records

            i.     Glomerulonephritis, especially rapidly progressive GN  were reviewed,  and clinical  and demographic
                                                                features (including self-reported ethnic group), the
            ii.     Pulmonary hemorrhage, especially pulmonary renal
               syndrome                                         department requesting the test, and comorbidities
            iii.   Cutaneous vasculitis with systemic features  were collated. The indication for each ANCA test
                                                                was assessed against the International Consensus
            iv.   Multiple lung nodules                         Statement of 1999.
            v.    Chronic destructive disease of the upper airways  The revised 2017 international  consensus on
            vi.   Long-standing sinusitis or otitis             ANCA testing recommends the use of high-quality
            vii.  Subglottic tracheal stenosis                  immunoassays  as  the  preferred  first  screening
            viii.   Mononeuritis multiplex or other peripheral   method for granulomatosis with polyangiitis (GPA)
                neuropathies                                    and microscopic  polyangiitis  [2], which remains
            ix.   Retro-orbital mass                            unchanged  in the  2020 consensus statement  [6].
            x.    Scleritis                                     The  recommendations  were  based  on  a  multi-
            Note: *when there is no other obvious cause.        center European Vasculitis Study Group evaluation
                                                                which demonstrated that these assays had a higher
           62% [3]. Encouragingly, studies show that AAV        diagnostic  performance  in comparison  to manual
           is seldom missed when testing  is restricted  to     and automated indirect immunofluorescence [7].
           indications listed in the 1999 clinical guidelines [3].  While the consensus statement does not specify
              AAV seems to be rare in African populations. Only   a particular  type of immunoassay to be used, a
           a limited number of studies on ANCA antibodies or    recent review from the Netherlands has indicated
           AAV in Africa have been reported, most likely due to   that, for routine screening, diagnosis, and follow-
           a combination of a low index of suspicion of AAV and   up, quantitative  assays measuring  ANCA levels
           a lack of appropriate laboratory facilities [4]. Among   are  associated  with  higher  likelihood  ratios  and
           a group of 60 West Africans, 6.7% of patients with   a  more  definitive  diagnosis  [8].  On  the  other
           chronic infections (tuberculosis [TB] and malaria)   hand, qualitative  immunoassays can be used
           tested positive for anti-myeloperoxidase (MPO). In   for  confirmation  and  rapid  testing  [8],  generally
           contrast, no ANCA antibodies were detected among     interpreted using a single cut-off value.
           healthy Africans [5].                                   The NHLS utilized a fluorescence enzyme-linked
              The rising cost of laboratory investigations and   immunosorbent assay sandwich immunoassay for
           equitable  distribution of healthcare  resources has   ANCA  testing.  The  specific  method  employed
           become  important  issues worldwide,  with  both     was the EliA IgG assay, performed on the Phadia
           social and political implications. In South Africa,   250  (Thermofisher).  This  in vitro qualitative
           cost-effectiveness is a major criterion in developing   measurement detects IgG antibodies directed against
           clinical policies. We audited all ANCA tests ordered   proteinase 3 (PR3) and MPO in human sera. Before
           in a tertiary academic hospital to assess adherence   analysis, the sample preparation includes allowing
           to  indications  for  testing,  evaluate  the  diagnostic   the serum to clot at room temperature, followed by
           accuracy of the test, and review the positive ANCA   centrifugation at 2200× g for 15 min. The serum
           test results, aiming to decrease hospital costs and   is then drawn off, and aliquots are transferred into
           avoid inappropriate specialist referrals. The Human   appropriately  labeled  tubes.  The  aliquot  samples
           Research Ethics Committee of the Faculty of Health   are immediately analyzed. The cutoff values (as per
                                                                kit manufacturer) for anti-PR3 and anti-MPO are
           Sciences, University of Cape Town, approved the      1.9 U/ml and 3.4 U/ml, respectively.
           study (HREC reference number 443/2018).
                                                                   Descriptive  statistics  and  normally  distributed
           2. Methods                                           variables  are  presented  as means  with  standard
                                                                deviations,  and  sensitivity,  specificity,  PPV,  and
           A retrospective record review was performed on all   NPV were calculated.  Analysis was conducted
           ANCA tests ordered through the National Health       using IBM SPSS Statistics V26.

                                                    ©2022 AccScience Publishing
   17   18   19   20   21   22   23   24   25   26   27